Ipsen (IPN.PA) traded down -0.66 % during a 24 hours period ending at 01:16 AM Central Europe on Tuesday 27th. One Ipsen stock can currently be bought for about EUR 151.5 on popular exchanges. Current supply of Ipsen stocks is 82 mn. Ipsen has a current market capitalization of EUR 12.4 bn and approximately EUR 28.8 mn worth of Ipsen was traded on exchanges in the last 24 hours. Since last month end, Ipsen has traded 1.41 % up. Simple moving average of last 200 days is at EUR 156.2. The highest price of past 52 weeks was recorded at EUR 174 on 07/31/2026. 52 weeks low was at EUR 115.6 on 12/19/2025.
Here is how related stocks have performed in the past 24 hours:
Klepierre (LI.PA) traded down -1.14 % and now trades at EUR 35.26. Current market capitalisation for Klepierre is EUR 10 bn. Current price/earnings ratio for Klepierre is 7.29.
Bureau Veritas (BVI.PA) traded down -0.48 % and now trades at EUR 29.1. Bureau Veritas has a market capitalisation of EUR 12.9 bn. Current price/earnings ratio for Bureau Veritas is 25.77.
Carrefour (CA.PA) traded up 1.1 % and now trades at EUR 13.78. Carrefour has a market capitalisation of EUR 9.8 bn. Carrefour has a current price to earnings ratio of 10.86.
Getlink (GET.PA) traded down -0.56 % and now trades at EUR 19.63. Current market capitalisation for Getlink is EUR 10.5 bn. Getlink has a current price to earnings ratio of 32.5.
Biomerieux (BIM.PA) traded up 1.08 % and now trades at EUR 88.85. Current market capitalisation for Biomerieux is EUR 10.5 bn. Biomerieux has a current price to earnings ratio of 22.8.
About Ipsen
Ipsen SA is a French pharmaceutical company that manufactures and markets a diverse range of medical drugs targeting various disease areas such as oncology, endocrinology, and neuromuscular disorders.